542709
2,6-二氟苯磺酰胺
97%
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
F2C6H3SO2NH2
化学文摘社编号:
分子量:
193.17
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
97%
InChI
1S/C6H5F2NO2S/c7-4-2-1-3-5(8)6(4)12(9,10)11/h1-3H,(H2,9,10,11)
SMILES string
NS(=O)(=O)c1c(F)cccc1F
InChI key
RVVVGGCOFWWDEL-UHFFFAOYSA-N
assay
97%
mp
187-191 °C (lit.)
functional group
fluoro
General description
2,6-Difluorobenzenesulfonamide is a fluorinated benzenesulfonamide that can be prepared by reacting 2,6-difluorobenzenesulfonyl chloride with 29% ammonium hydroxide. It forms complexes with human carbonic anhydrase II (HCA). X-ray crystal structure of these complexes have been studied.
Application
2,6-Difluorobenzenesulfonamide can be prepared from N-(4-chlorophenyl)-N′-[(2,6-di fluorophenyl)-sulfonyl]urea.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Insect growth regulators. Analogs of TH-6038 and TH-6040.
Oliver JE, et al.
Journal of Agricultural and Food Chemistry, 24(5), 1065-1068 (1976)
Shruthi Vaidhyanathan et al.
The Journal of pharmacology and experimental therapeutics, 356(2), 251-259 (2015-11-26)
Small molecule inhibitors targeting the mitogen-activated protein kinase pathway (Braf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase) have had success in extending survival for patients with metastatic melanoma. Unfortunately, resistance may occur via cross-activation of alternate signaling pathways. One approach to overcome
Vijay M Krishnamurthy et al.
Chemistry, an Asian journal, 2(1), 94-105 (2007-04-19)
This paper describes a calorimetric study of the association of a series of seven fluorinated benzenesulfonamide ligands (C6H(n)F(5-n)SO2NH2) with bovine carbonic anhydrase II (BCA). Quantitative structure-activity relationships between the free energy, enthalpy, and entropy of binding and pKa and log
Shruthi Vaidhyanathan et al.
Drug metabolism and disposition: the biological fate of chemicals, 42(8), 1292-1300 (2014-05-31)
Brain metastases are a major cause of mortality in patients with advanced melanoma. Adequate brain distribution of targeted agents for melanoma will be critical for treatment success. Recently, improvement in overall survival led to US Food and Drug Administration (FDA)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持